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VALVE SURGERY: RESULTS OF




We read with great interest the
recent publication by Santana and
colleagues,1 entitled ‘‘Staged Percuta-
neous Coronary Intervention and Min-
imally Invasive Valve Surgery: Results
of a Hybrid Approach to Concomitant
Coronary and Valvular Disease.’’ A to-
tal of 65patientswhounderwent staged
percutaneous coronary intervention
andminimally invasive cardiac surgery
(MICS) valve surgery were compared
with 51 patients who underwent com-
bined valve/coronary artery bypass
grafting. The authors are to be congrat-
ulated for their excellent short-term1684 The Journal of Thoracic andresults in the MICS group, particularly
the lack of mortality. However, draw-
ing conclusions between the 2 groups
is problematic in that there were 6 dif-
ferent surgeons in the control group
versus 1 surgeon in the MICS group.
It iswell known thatmortality andmor-
bidity rates in valve surgery are highly
correlated to the caseload of the indi-
vidual surgeon.2 We would question if
the 28% versus 1.5% cumulative inci-
dence of adverse short-term outcomes,
including death, stroke, and renal fail-
ure, in the control versus the experi-
mental group is merely a reflection of
this fact.
Another concern is 61 of 65 patients
in the hybrid group had percutaneous
coronary intervention of the left anterior
descending artery before MICS, and
only 55.5% of the stentswere drug elut-
ing. In view of the the well-documented
durability of the left internal thoracic ar-
tery to the left anterior descending ar-
tery, with both its salutary impact on
longevity and major adverse cardiac
outcomes, are these patients possibly
being shortchanged in the zeal to per-
form MICS?
We also noted that in the MICS mi-
tral cohort, there was only a 58% re-
pair rate (14/24) despite no mention
of rheumatic causes. Other than 6 cal-
cific mitral valves, it seems plausible
that the repair rate should have been
higher in the hands of such a high-
volume surgeon. Again, perhaps the
lack of adequate exposure inherent to
a ‘‘4- to 5-cm’’ MICS incision com-
promised the ability to attain a satis-
factory repair.
Finally, nowhere in the article was
there any mention of atrial fibrillation
(AF). It is unlikely that none of these
patients would have any preoperative
history of such. Ad and colleagues3
recently reported that only 40.6% of
patients with a history of AF have it
addressed at the time of concomitant
heart surgery. Knowing the favorable
effects of a concomitant Cox-maze
on ejection fraction, stroke, and life
span, as well as the fact that this pro-
cedure can be applied via a MICSCardiovascular Surgery c June 2013approach, the authors should recon-
sider their strategy in those patients
with a significant history of AF.
We applaud this and other efforts to
make cardiac surgery less invasive.
However, suboptimal mitral repair
rates and infrequent use of the left
internal thoracic artery, as well as
overlooking preoperative AF, may
significantly compromise long-term
patient outcomes.
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OF THE SAME COIN?
To the Editor:
Jakobsen and colleagues1 are to
be congratulated for pursuing alterna-
tives to supranormal potassium cardio-
plegia in cardiac surgery. Since
a 15-year moratorium was placed on
Melrose’s hyperkalemic solution in the
late 1950s, investigators in cardiopro-
tection have attempted to find a method
